Aortic Valve Replacement
Find comprehensive information on Aortic Valve Replacement (AVR), including clinical documentation and medical coding for Aortic Valve Surgery. This resource covers Aortic Valve Replacement Surgery diagnosis, providing healthcare professionals with essential insights for accurate and efficient documentation and coding practices. Learn more about AVR and related terms for optimal clinical care and medical record keeping.
Surgical replacement of a diseased aortic valve with a prosthetic valve.
Shortness of breath, chest pain, fainting, heart murmur, leg swelling.
Hospital operating room, cardiac surgery unit, cardiothoracic surgery.
ICD-10 Code Families
Complete code families applicable to Z95.2
When to use each related code
| Description | When to use |
|---|---|
| Replacement of diseased aortic valve. | Use for surgical replacement of aortic valve due to stenosis, regurgitation, or other dysfunction. |
| Repair of damaged aortic valve. | Use when the aortic valve is repaired, not replaced. Includes procedures like valvuloplasty. |
| Transcatheter aortic valve replacement. | Use for minimally invasive aortic valve replacement via catheter, not open-heart surgery. Includes TAVR, TAVI. |
Best-practice checklist
- ✓Document pre-op aortic valve function.
- ✓Specify type of AVR: mechanical, bioprosthetic, or Ross.
- ✓Note valve size and manufacturer.
- ✓Document intraoperative findings/complications.
- ✓Record post-op valve function assessment.
Common pitfalls to avoid
Coding requires specifying approach (transcatheter, open) for accurate reimbursement and quality reporting. Missing approach can lead to claim denials or incorrect DRG assignment.
Documentation must specify the type of valve implanted (mechanical, bioprosthetic, etc.) impacting coding, outcomes analysis, and future patient care.
Accurate capture of comorbidities (e.g., heart failure, hypertension) is crucial for proper risk adjustment, affecting reimbursement and quality metrics.
Best-practice tips
- 01Document pre-op aortic valve state (stenosis, regurgitation).
- 02Specify AVR type: mechanical, bioprosthetic, or Ross procedure.
- 03Code valve size, location, and approach (open, minimally invasive).
- 04Record intraoperative complications and post-op echo findings.
- 05Query physician for clarity if documentation is vague or missing key details.
Step-by-step checklist
- 1
Verify symptomatic severe AS: angina, syncope, or HF.
- 2
Confirm diagnosis with echocardiography: assess valve area & gradient.
- 3
Assess LVEF and other cardiac risk factors pre-op.
- 4
Document NYHA functional class and operative risk assessment.
- 5
Review patient understanding of risks/benefits of AVR.
Ready-to-paste narrative
Patient presents for evaluation and management of aortic stenosis, prompting consideration for aortic valve replacement (AVR). Symptoms include dyspnea on exertion, angina pectoris, and syncope, consistent with the diagnostic criteria for severe aortic stenosis. Physical examination revealed a systolic ejection murmur radiating to the carotids. Echocardiography confirms severe aortic valve stenosis with a mean gradient of [insert value] mmHg and an aortic valve area of [insert value] cm2. Left ventricular hypertrophy is also noted. The patient's medical history includes hypertension and hyperlipidemia, managed with [list medications]. Surgical risks and benefits of aortic valve replacement surgery, including bioprosthetic valve vs. mechanical valve options, were discussed with the patient. After a thorough assessment, the decision was made to proceed with aortic valve replacement. Preoperative clearance and cardiac catheterization are scheduled. This procedure is medically necessary due to the severity of the patient's aortic stenosis and symptomatic presentation. ICD-10 code I35.0 (Aortic valve stenosis) and CPT code 33405 (Aortic valve replacement, using open approach) are relevant for this encounter. Postoperative care and follow-up will be discussed with the patient and family.
Common questions and answers
What are the key considerations for deciding between mechanical and bioprosthetic aortic valve replacement in a low-risk patient?+
Choosing between a mechanical and bioprosthetic aortic valve replacement (AVR) for low-risk patients requires careful consideration of individual factors. Mechanical valves offer greater durability, eliminating the need for future re-operations, but necessitate lifelong anticoagulation therapy, increasing the risk of bleeding complications. Bioprosthetic valves, derived from animal tissue or human donors, have a limited lifespan but usually do not require long-term anticoagulation. For younger, low-risk patients, the longevity of a mechanical valve may outweigh the bleeding risks associated with anticoagulants. However, older patients or those with contraindications to anticoagulation may benefit more from a bioprosthetic valve, accepting the possibility of a future re-operation. Shared decision-making, incorporating patient preferences and a thorough risk-benefit analysis based on the latest clinical guidelines, is crucial for optimal outcomes. Explore how different valve types impact long-term patient management strategies by reviewing the current AHA/ACC guidelines on valvular heart disease.
How can I best manage post-operative anticoagulation therapy following mechanical aortic valve replacement to minimize bleeding risk?+
Managing post-operative anticoagulation therapy after mechanical aortic valve replacement (AVR) is vital to minimize bleeding risk while preventing thromboembolic complications. The target international normalized ratio (INR) for patients with a mechanical aortic valve is typically between 2.0 and 3.0, though this can vary depending on individual patient factors and the specific type of mechanical valve. Frequent INR monitoring, especially in the initial post-operative period, is essential to adjust warfarin dosage accurately. Patient education on dietary considerations, potential drug interactions (including over-the-counter medications and herbal supplements), and signs and symptoms of bleeding is crucial. Consider implementing a standardized protocol for INR monitoring and dose adjustment based on the latest clinical evidence. Learn more about best practices for managing anticoagulation therapy in post-AVR patients to optimize patient safety and outcomes.
What are the most effective strategies for minimizing the risk of paravalvular leak after aortic valve replacement surgery?+
Minimizing the risk of paravalvular leak (PVL) after aortic valve replacement (AVR) requires a multi-pronged approach focusing on surgical technique, patient selection, and post-operative management. Intraoperative transesophageal echocardiography (TEE) plays a critical role in assessing valve seating and identifying potential leaks during the procedure, enabling timely intervention. Precise suture placement and an understanding of the intricacies of different valve prosthesis designs are essential for achieving optimal results. Pre-operative assessment should identify patients at increased risk of PVL, such as those with extensive calcification, challenging anatomy, or a history of endocarditis. Post-operatively, careful monitoring for signs and symptoms of PVL, such as heart failure or hemolysis, is crucial. Explore how advances in surgical techniques and imaging technologies contribute to minimizing PVL incidence and improving long-term outcomes following AVR.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.